参考文献/References:
[1] 冯璇,寇玉,薛峰,等.半夏泻心汤治疗胃黏膜异型增生疗效及对患者胃癌相关基因甲基化的影响[J].陕西中医,2021,42(8):1020-1023.
[2] 张鑫,田蕾,朱金朋,等.微小RNA-135a-5p和Krüppel样因子16在胃腺癌中的表达及靶向关系研究[J].陕西医学杂志,2022,51(12):1597-1601.
[3] ZHANG S,YANG Y,HUANG S,et al.SIRT1 inhibits gastric cancer proliferation and metastasis via STAT3/MMP-13 signaling[J].J Cell Physiol,2019,234(9):15395-15406.
[4] SAMMARCO G,VARRICCHI G,FERRARO V,et al.Mast cells,angiogenesis and lymphangiogenesis in human gastric cancer[J].Int J Mol Sci,2019,20(9):2106.
[5] 何瑜,唐宽平,马晓颖.5-钙黏蛋白、基质金属蛋白酶9在结直肠癌组织中的表达及临床意义[J].陕西医学杂志,2021,50(5):618-621.
[6] 柳金凤,周厚菊.卵巢癌患者血清MMP12、MMP13水平与临床病理参数和预后的关系[J].中国妇幼保健,2019,34(19):4411-4415.
[7] GOBIN E,BAGWELL K,WAGNER J,et al.A pan-cancer perspective of matrix metalloproteases(MMP)gene expression profile and their diagnostic/prognostic potential[J].BMC Cancer,2019,19(1):581.
[8] LIU A D,PANG J L,XIONG G Y,et al.Forkhead box P4 promotes the proliferation of cells in colorectal adenocarcinoma[J].Oncologie,2023,25(5):543-552.
[9] 刘爱东,张爽,王丹琳,等.MMP-19在胃腺癌中的表达及与神经型钙黏素的相关性[J].重庆医科大学学报,2022,47(2):145-150.
[10] 贾丽.大蒜素对人子宫内膜癌Ishikawa细胞侵袭和迁移抑制作用的研究[J].陕西中医,2020,41(8):1042-1046.
[11] 刘时飞,刘爱东,宋旭东,等.胃腺癌中eIF2α的表达及意义[J].临床与实验病理学杂志,2018,34(6):668-670.
[12] 李向阳,任磊,梁瑞.血清基质金属蛋白酶-9、基质金属蛋白酶-2水平对胃癌腹膜转移及预后的预测价值[J].陕西医学杂志,2023,52(2):166-170.
[13] LI M D,ZHOU L,LI S Y,et al.MMP12 is a potential therapeutic target for adamantinomatous craniopharyngioma:Conclusions from bioinformatics analysis and in vitro experiments[J].Oncology Letters,2021,22(1):5-10.
[14] LIU M,HUANG L,LIU Y,et al.Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma[J].J Transl Med,2023,21(1):208.
[15] DEL-PORTO F,DI-GIOIA C,TRITAPEPE L,et al.The multitasking role of macrophages in stanford type A acute aortic dissection[J].Cardiology,2014,127(2):123-129.
[16] YUN S P,LEE S J,OH S Y,et al.Reactive oxygen species induce MMP12-dependent degradation of collagen 5 and fibronectin to promote the motility of human umbilical cord-derived mesenchymal stem cells[J].Br J Pharmacol,2014,171(13):3283-3297.
[17] GUO Z Y,JIANG L P.Matrix metalloproteinase 12(MMP12)as an adverse prognostic biomarker of vascular invasion in hepatic cell carcinoma[J].Eur Rev Med Pharmacol Sci,2022,26(7):2238-2249.
[18] LV F Z,WANG J L,WU Y,et al.Knockdown of MMP12 inhibits the growth and invasion of lung adenocarcinoma cells[J].Int J Immunopathol Pharmacol,2015,28(1):77-84.
[19] CHUNG I C,CHEN L C,CHUNG A K,et al.Matrix metalloproteinase 12 is induced by heterogeneous nuclear ribonucleoprotein K and promotes migration and invasion in nasopharyngeal carcinoma[J].BMC Cancer,2014,14:348.
[20] LUO Y H,YUAN L,LU D D,et al.The mechanism of dehydroandrographolide inhibiting metastasis in gastric cancer based on network pharmacology and bioinformatics[J].Medicine(Baltimore),2023,102(34):e34722.
[21] ZHANG W,LI G S,GAN X Y,et al.MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma[J].Peer J,2023,11:e15598.
[22] BERES B,YUSENKO M,PETERFI L,et al.Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma,a short report[J].Cell Oncol(Dordr),2022,45(1):193-198.
[23] GAO H,ZHOU X,LI H,et al.Role of matrix metallopeptidase 12 in the development of hepatocellular carcinoma[J].J Invest Surg,2021,34(4):366-372.
[24] XIE J,ZHOU X,WANG R,et al.Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma[J].Medicine(Baltimore),2021,100(23):e26135.
[25] 刘爱东,刘时飞,熊光宜,等.真核翻译起始因子2α促进结直肠腺癌细胞增殖[J].中华实验外科杂志,2022,39(9):1752-1754.
[26] HE M K,LE Y,ZHANG Y F,et al.Matrix metalloproteinase 12 expression is associated with tumor FOXP3+ regulatory T cell infiltration and poor prognosis in hepatocellular carcinoma[J].Oncol Lett,2018,16(1):475-482.
[27] HAN F,ZHANG S,ZHANG L,et al.The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma[J].Pathol Res Pract,2017,213(12):1519-1522.
相似文献/References:
[1]侯洁心 ,郭萍△.免疫组化标志物Her2和肿瘤标志物在胃癌诊断中的价值分析*[J].陕西医学杂志,2019,(1):121.
HOU Jiexin,GUO Ping..The value of immunohistochemical marker Her2 andtumor markers in the diagnosis of gastric cancer[J].,2019,(6):121.
[2]唐亚荣.循环热灌注化疗联合替吉奥及热疗治疗老年胃癌癌性腹水临床研究*[J].陕西医学杂志,2019,(4):435.
TANG Yarong..Clinical effect analysis of combined therapy with tiago and hyperthermia in the treatment of malignant ascites in elderly patients with gastric cancer[J].,2019,(6):435.
[3]刘国庆,闫 龙△,高 任.1.5T磁共振扩散加权成像在胃癌淋巴结转移诊断中的应用价值*[J].陕西医学杂志,2019,(4):456.
LIU Guoqing,YAN Long,GAO Ren..1.5T magnetic resonance diffusion weighted imaging in the diagnosis of lymph node metastasis of gastric cancer[J].,2019,(6):456.
[4]胡乃军,王海龙.胃腺癌组织中MMP11、MMP12和VEGFD的表达及临床意义[J].陕西医学杂志,2019,(5):554.
[5]米志宽,赵菊梅.抑癌基因甲基化与胃癌关系研究进展*[J].陕西医学杂志,2019,(5):679.
MI Zhikuan,ZHAO Jumei..Research progress of relationships between tumor suppressor gene methylation and gastric cancer[J].,2019,(6):679.
[6]石颖鹏,王敏娟,李程亮.肠化生相关分子与胃癌的发生和进展研究概况[J].陕西医学杂志,2019,(7):958.
SHI Yingpeng,WANG Minjuan,LI Chengliang,et al.Intestinal metaplasia-related molecules and the occurrence and progress of gastric cancer[J].,2019,(6):958.
[7]郭小艳,于桂萍.抗幽门螺杆菌疗法联合新辅助化疗对胃癌术后疗效及患者血清VEGF、bFGF的影响[J].陕西医学杂志,2019,(8):1010.
GUO Xiaoyan,YU Guiping..Effect of anti-Helicobacter pylori therapy combined with neoadjuvant chemotherapy on serum VEGF and bFGF in postoperative patients with gastric cancer[J].,2019,(6):1010.
[8]柯东平,毛俊倩,郭甲民,等.SCNN1B与胃癌细胞上皮间质转化相关性实验研究*[J].陕西医学杂志,2019,(9):1115.
KE Dongping,MAO Junqian,GUO Jiamin,et al.Research on the correlation between SCNN1B and〖JZ〗 epithelialmesenchymal transformation in gastric cancer cells[J].,2019,(6):1115.
[9]王小林,马任远,张 哲.腹腔镜手术治疗老年进展期胃癌50例临床疗效分析[J].陕西医学杂志,2019,(10):1360.
[10]刘维帅,郭晓宁,杨 洋,等.胃癌病理类型及临床预后与血清miR-133a和DKK-1相关性分析[J].陕西医学杂志,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]
LIU Weishuai,GUO Xiaoning,YANG Yang,et al.Correlation of pathological types and clinical prognosis of gastric cancer with serum miR-133a and DKK-1[J].,2020,49(6):751.[doi:DOI:10.3969/j.issn.10007377.2020.06.028]